10 employees
GeneAssess is a New Jersey-based biotechnology company working to validate FRY, a cancer molecular signature gene.
2012
$500K
from 1 investors over 1 rounds
GeneAssess, Inc. raised $500K on July 2, 2012
Investors: Foundation Venture Capital Group, LLC